Navigation Links
Mesa Labs Reports 18% Increase in Third Quarter Revenues
Date:2/5/2013

e for that period multiplied by the amortization. We believe that excluding these acquisition related expenses provides the ability to understand the benefits of acquisitions based on their cash return.

We provide non-GAAP net income and non-GAAP net income per share amounts in order to provide meaningful supplemental information regarding our operational performance. Our management uses non-GAAP measures to evaluate the performance of our business and to compensate employees. This information facilitates management's internal comparisons to our historical operating results as well as to the operating results of our competitors. Since management finds this measure to be useful, we believe that our investors can benefit by evaluating both non-GAAP and GAAP results.

Our management recognizes that items such as amortization of intangibles can have a material impact on our net income. To gain a complete picture of all effects on our profit and loss from any and all events, management does (and investors should) rely upon the GAAP statements of income. The non-GAAP numbers focus instead upon our core operating business.

Readers are reminded that non-GAAP measures are merely a supplement to, and not a replacement for, or superior to financial measures prepared according to GAAP. They should be evaluated in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.

About Mesa Laboratories, Inc.

We pursue a strategy of focusing primarily on quality control products, which are sold into niche markets that are driven by regulatory requirements. We prefer markets that have limited competition where we can establish a commanding presence and achieve high gross margins.  We are organized into two divisions across four physical locations.  Our Instruments division designs, manufactures and markets quality control ins
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, for ... surveyed U.S. and European rheumatologists cite a therapy,s ... that most influences their prescribing decisions. Over 60 ... rheumatologists, respectively, rank the percentage of patients achieving ...
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a ... BDX ), a leading global medical technology company, today announced ... , the latest in its line of high-performance research flow ... delivers high-performance multicolor analysis with the most compact footprint in ... cm) and a height of 30" (76.2 cm). Recognizing that ...
(Date:6/19/2013)... 19, 2013 /PRNewswire-iReach/ -- In its first ... pharmaceutical company dedicated to advancing development of ... sustained release drug therapies in patient disease ... announced the acquisition of Enzon Pharmaceutical,s PEGylation ... associated product pipeline. Acquisition of this technology ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
...   SAP America Inc., a subsidiary of ... SAP ), today introduced the SAP® Collaborative E-Care Management application ... the application aims to connect care providers, patients and their ... at HIMSS 2012 , being held February 20–24 in ...
... SurgLine International, Inc. (SGLN.PK). Thomas Toland, ... the past six months we have made certain public ... contracts and a pending acquisition in an effort to ... Our management team has completed an internal ...
Cached Medicine Technology:Newsbyte: SAP to Integrate Healthcare in the Community Through Collaborative Care 2SurgLine International, Inc. Update to Shareholders on Revenue Pipeline and Organizational Changes 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 DiscountFurnaceFilter.com, the number ... to offer the 5-2-1 Compressor Saver kit at an exceptional ... Start Kit) aids the air conditioning unit during start up, ... prevent air compressor or unit burn out. , The ... so the air conditioner uses less power to start and ...
(Date:6/19/2013)... Alternatives, a revolutionary new treatment facility ... using drugs while allowing them to continue drinking alcohol. ... Alternatives, believe that abstinence-only approaches force people to wait ... that this approach hurts instead of helping. It ... States need treatment for addiction but only 3 million ...
(Date:6/19/2013)... Kansas City, MO (PRWEB) June 19, 2013 Kansas ... as part of Main Street Day . A section of ... and pedestrian traffic during the afternoon of the event. The ... to host the event, which will help Kansas City join the ... have used Ciclovia as a tool to foster community vibrancy and ...
(Date:6/19/2013)... Many trying-to-conceive couples seek medical intervention ... to a recent study published in ... of this research confirm what Fairhaven Health has ... that trying-to-conceive women would benefit from tracking ovulation, ... Fairhaven Health is a leading provider of ovulation ...
(Date:6/19/2013)... 19, 2013 In 2011, the value ... 710 million. Generic drugs form the largest sector, accounting ... The pharmaceutical industry is a significant contributor to the ... country’s GDP. Approximately 50% of the total domestic chemical ... industry. Hemofarm, Galenika and Zdravlje Actavis are key participants ...
Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2
... bird, Paris Hilton, is reportedly having a tough time with ... video, One Night In Paris , with ex- beau Rick ... at the Lynwood centre by saying 'Paris sure knows how ... ,A jail inmate, Danita Daniel, said that prisoners were constantly ...
... about racial inequalities, even at the cost of lives, are ... finds that blacks are far less likely than whites ... heart attack, which leave them more vulnerable to future fatal ... Journal of the American Medical Association, tracked 1.2 million Medicare ...
... the prosthesis that has helped thousands of disabled worldwide to ... first centre on foreign soil . ,The Colombian government ... of the artificial limb, to set up base in the ... with a Colombia-based NGO. ,M.K. Mathur of BMVSS ...
... new study, skin cancer levels have shown a significant increase ... is more likely to affect those living in more affluent ... people are more prone to the disease. ,Researchers, ... over a 12-year period, reported a 20 per cent increase ...
... informed by my physician that what I "thought" to be a ... me without antibiotics I could wind up in the hospital . ... can afford to "die" because I have life insurance, only I ... "abuse" is. It is the over inflated prices of medical care ...
... new study has emphasised the safety and efficacy of ... (RA) patients . ,Biologics, such as etanercept, ... protein in the body called tumour necrosis factor that ... etanercept, also known as an anti-TNF therapy, etanercept has ...
Cached Medicine News:Health News:Racial Discrimination Takes The Nobility Out Of Doctoring 2Health News:Jaipur Foot All Set to Launch Its Centre in Columbia 2Health News:Deadly Skin Cancer Bites the Rich Harder 2Health News:Deadly Skin Cancer Bites the Rich Harder 3Health News:Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore 2Health News:Study Reinforces Safety of Long-term Biologic Treatment for Rheumatoid Arthritis 2
FlexStationII offers the highest level of flexibility in developing functional cellular assays and analyzing real time kinetic data....
... C&L Dye Fluorometer utilizes unique microprocessor-controlled filter ... and detection optics. The filter wheels can ... numerous types of applications. With this fluorometer, ... measuring one or two wavelengths. The C&L ...
... is a multifunctional single ... give you utmost flexibility ... and absorbance. Modulus operates ... dedicated luminometer, or a ...
The VICTOR² D fluorometer is suitable for clinical assays based on fluorescence or time-resolved fluorescence from a wide variety of plates....
Medicine Products: